Insulin pump therapy in children and teenagers;Insulinpumpebehandling af børn og unge

Ugeskrift for Laeger

Volumn 171, Issue 23, 2009, Pages 1913-1918

  Bergholtz, Carl Henrik ^a   Olsen, Birthe ^a   Johannesen, Jesper ^a  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

ADOLESCENT; ADULT; BLOOD; CHILD; EVIDENCE BASED MEDICINE; HUMAN; INFANT; INFUSION PUMP; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; OUTCOME ASSESSMENT; PRESCHOOL CHILD; REVIEW;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; EVIDENCE-BASED MEDICINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INFUSION PUMPS, IMPLANTABLE; INSULIN; INSULIN INFUSION SYSTEMS; OUTCOME ASSESSMENT (HEALTH CARE); YOUNG ADULT;

EID: 67649111868     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. DCCT Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus. Diabetes Control and Complications Trial. J Pediatr 1994;125:177-88.
2. EDIC Research Group. Sustained effect of intensive treatment of type 1-diabetes mellitus on development and progression of diabetic nephropathy: EDICT. JAMA 2003; 290: 2159-67.
3. Pickup JC, Keen H, Parsons JA et al. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Br Med J 1978;1:204-7.
4. Tamborlane WV, Sherwin RS, Genel M et al. Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 1979;300:573-8.
5. Hanas R, Ludvigsson J. Hypoglycemia and ketoacidosis with insulin pump therapy in children and adolescents. Pediatric Diabetes 2006;7:32-38.
6. Pickup J, Mattock M, Kerry S. Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1-diabetes: meta-analysis of randomised controlled trials. BMJ 2002;324:705.
7. Olsen BS, Johannesen J. Insulinpumpe til børn med type 1-diabetes. Ugeskr Læger 2007;169:1101.
8. Fox LA, Buckloh LM, Smith SD et al. A randomized controlled trail of insulin pump therapy in young children with type 1-diabetes. Diabetes Care 2005;28:1277-81.
9. DiMeglio LA, Pottorff TM, Sheryl R et al. A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatrics 2004;145:380-4.
10. Olsen BS, Andersen MM, Mortensen HB et al. Insulin pump treatment in children with type 1-diabetes: a study of patient preferences, satisfaction and metabolic control. Pediatric Diabetes 2006;37:P53.
11. Behre T, Postellon D, Wilson B et al. Feasibility and safety of insulin pump therapy in children aged 2 to 7 years with type 1-diabetes: a retrospective study. Pediatrics 2006;117:2132-7.
12. Nimri R, Weintrob N, Benzaquen H et al. Insulin pump therapy in youth with type 1-diabetes: a retrospective paired study. Pediatrics 2006;117:2126-31.
13. Weinzimer SA, Ahern JA H, Doyle EA et al. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1-diabetes: A followup report. Pediatrics 2004;114:1601-5.
14. Ahern JAH, Boland EA, Doane R et al. Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups. Pediatric Diabetes 2002;3:10-15.
15. Mack-Fogg JE, Orlowski C, Jospe N. Continuous subcutaneous insulin infusion in toddlers and children with type 1-diabetes mellitus is safe and effective. Pediatric Diabetes 2005;6:17-21.
16. Willi SM, Planton J, Egede L et al. Benefits of continuous subcutaneous insulin infusion in children with type 1-diabetes. J Pediatrics 2003;143:796-801.
17. Conrad SC, McGrath MT, Gitleman SE. Transition from multiple daily injections to continuous subcutaneous insulin infusion in type 1-diabetes mellitus. J Pediatrics 2002;140:235-40.
18. Rabbone I, Bobbio A, Berger K et al. Age-related differences in metabolic response to continuous subcutaneous insulin infusion in pre-pubertal and pubertal children with Type 1-diabetes mellitus. J Endocrinol Invest 2007;30:477-83.
19. Doyle EA, Weinzimer SA, Steffen AT et al. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004;27:1554-8.
20. Weintrob N, Benzaquen H, Galatzer A et al. Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1-diabetes: a randomized open crossover trial. Pediatrics 2003;112:559-64.
21. Alemzadeh R, Ellis JN, Holzum MK et al. Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1-diabetes. Pediatrics 2004;114:91-5.
22. Boland EA, Grey M, Oesterle A et al. Continuous subcutaneous insulin infusion - a new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1-diabetes. Diabetes Care 1999;22:1779-84.
23. Johannesen J, Eising S, Kohlwes S et al. Treatment of Danish adolescent diabetic patients with CSII - a matched study to MDI. Pediatric Diabetes 2008;23:23-8.
24. Júlíusson PK, Graue M, Wentzel-Larsen T et al. The impact of continuous subcutaneous insulin infusion on health-related quality of life in children and adolescents with type 1-diabetes. Acta Pædiatrica 2006;95:1481-7.
25. Plotnick LP, Clark LM, Brancati FL et al. Safety and effectiveness of insulin pump therapy in children and adolescents with type 1-diabetes. Diabetes Care. 2003;26:1142-6.
26. Maniatis AK, Klingensmith GJ, Slover RH et al. Continuous subcutaneous insulin infusion therapy for children and adolescents: An option for routine diabetes care. Pediatrics 2001;107:351-6.
27. Hanas R, Adolfsson P. Insulin pumps in pediatric routine care improve long-term metabolic control without increasing the risk of hypoglycaemia. Pediatric diabetes 2006;7:25-31.
28. Wood JR, Moreland EC, Volkening LK et al. Durability of insulin pump use in pediatric patients with type 1-diabetes. Diabetes Care 2006;29:2355-60.
29. Reda E, Von Reitzenstein A, Dunn P. Metabolic control with insulin pump therapy: the Waikato experience. N Z Med J 2007;120:U2401.
30. Bulsara MK, Holman C, DÀ J, Davies EA et al. The impact of a decade of changing treatment on rates of severe hypoglycemia in a population-based cohort of children with type 1-diabetes. Diabetes Care 2004;10:2293-8.
31. Valenzuela JM, Patino AM, McCullough J et al. Insulin pump therapy and health-related quality of life in children and adolescents with type 1-diabetes. J Pediatric Psychol 2006;31:650-60.
32. Streisand R, Swift E, Wickmark T et al. Pediatric parenting stress among parents of children with type 1-diabetes: the role of self-efficacy, responsibility, and fear. J Pediatr Psychol 2005;30:513-21.
33. Chantelau E, Spraul M, Muhlhauser I et al. Long term safety, efficacy and side effects of continuous subcutaneous insulin infusion treatment for type 1 (insulin-dependent) diabetes mellitus: a one centre experience. Diabetologia 1989;32:421-6.
34. Danne T, von Schutz W, Lange K et al. Current practice of insulin pump therapy in children and adolescents - The Hannover recipe. Pediatr Diabetes 2006;7:25-31.
35. Technology Appraisal No 57. Guidance on the use of continuous insulin infusion for diabetes. February 2003. National Institute for Clinical Excellence, London. www.nice.org.uk (10. juni 2008).
36. Hovorka R. Continuous glucose monitoring and closed-loop systems. Diabet Med 2006;231:1-12.